Advertisement
Advertisement

Read Now: HIV 2014 Year in Review >>

International News

Less-Used HIV Treatment for African Children More Effective

May 2, 2013

Children living with HIV in sub-Saharan Africa can be treated with one of two antiretroviral drugs nevirapine or efavirenz. Most countries use nevirapine because it is less expensive and a pediatric formula is more readily available. Researchers in the United States and Botswana compared the effectiveness of both drugs and found initial treatment with efavirenz had better results. Elizabeth Lowenthal of the Children's Hospital of Philadelphia and lead author of the study noted that prices for bulk drug purchases are lower after negotiations between health officials and pharmaceutical companies. Robert Gross, the study's senior author and a University of Pennsylvania professor, stated that more could be done to make the drug financially viable for treating children in resource-limited settings.

The full report, "Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children," was published in the Journal of the American Medical Association (2013; 309(17):1803–1809).

Back to other news for May 2013

Adapted from:
Voice of America News
04.30.2013




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement